News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
144 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
BioAmber Announces Pricing of $10M Underwritten Public Offering
The Series A warrants have an exercise price of US$0.25 and a term of six months, exercisable upon the date of issuance.
February 6, 2018
·
5 min read
Biotech Bay
BioVentrix Achieves 2018 NUB Reimbursement Status 1 in Germany for Revivent TC TransCatheter Ventricular Enhancement System
BioVentrix today announced a significant reimbursement achievement.
February 6, 2018
·
2 min read
Business
ImaginAb Appoints Ian Wilson as COO
Mr. Wilson is an experienced diagnostic veteran with over 25 years of leadership in commercial development of in vivo medical diagnostics and imaging medical devices.
February 6, 2018
·
2 min read
Business
Bio-Techne Releases Second Quarter Fiscal 2018 Results
Bio-Techne today reported its financial results for the second quarter ended December 31, 2017.
February 6, 2018
·
28 min read
Biotech Beach
MabVax Therapeutics Closes $2.1M Private Placement Financing
Of the purchase agreements accepted, investors elected $1.4 of shares of Series M Preferred Stock.
February 6, 2018
·
7 min read
Pharm Country
Newron Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York
Newron announced that Stefan Weber, CEO, will present at the 20th Annual BIO CEO & Investor Conference in New York, NY on Monday, Feb. 12, 2018 at 10:15 a.m. ET in the Wilder Room at the New York Marriott Marquis.
February 6, 2018
·
2 min read
Business
Liquidia Technologies Appoints Kevin Gordon as President and Chief Financial Officer
Mr. Gordon will oversee finance operations and strategy, corporate development and legal functions.
February 6, 2018
·
3 min read
Business
EVER Pharma Adopts Veeva OpenData and Veeva CRM to Transform Customer Engagement
Veeva Systems announced that specialty pharmaceutical company EVER Pharma adopted Veeva OpenData and Veeva CRM to empower its growing team in Poland with the accurate customer data necessary to drive smarter, tailored engagement with healthcare professionals (HCPs).
February 6, 2018
·
4 min read
Drug Development
Pharma Two B Ltd. Release: First Patients Dosed in Phase III Multi-Center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson’s Disease
“This fundraising enables Pharma Two B to complete the Phase III and expand its pipeline.”
February 6, 2018
·
2 min read
OncoQuest Completes US$6 Million Private Placement
The financing was led by a South Korean institutional fund. Under the private placement, the Company issued 603,000 common shares at US$10.00 share.
February 6, 2018
·
3 min read
Previous
5 of 15
Next